Searchable abstracts of presentations at key conferences in endocrinology

ea0073pep10.8 | Presented ePosters 10: Thyroid | ECE2021

Transient hyperthyrotropinemia in outpatient children treated due to acute infections of the respiratory system

Adamczewska Katarzyna , Adamczewski Zbigniew , Stasiak Magdalena , Lewinski Andrzej , Stawerska Renata

IntroductionDiagnostics of thyroid dysfunctions is frequently based on the measurements of TSH serum concentration only. Currently, due to a tendency to minimize stressful situations for a child (such as venipuncture to take a blood sample), some tests (i.e. TSH assessment) are performed at the Primary Healthcare Centre while other diagnostic tests (e.g. during an infection) are run. If TSH serum concentration is outside the reference range, it leads to ...

ea0073aep518 | Pituitary and Neuroendocrinology | ECE2021

Spontaneous remission in Cushing’s disease: A case report

Radvilė Dobrovolskytė , Birutė Žilaitienė , Knispelis Robertas , Renata Pauliukienė

Spontaneous remission of Cushing disease might be a phase of cyclic disease, but could also be explained by an ACTH-microadenoma infarction or hemorrhage. True remission must be differentiated from cyclic Cushing’s disease with prolonged follow up. 63-years-old female patient was referred to endocrinologist’s and presented with uncontrolled hypertension, type 2 diabetes, central obesity, hirsutism, swelling of the face and legs and a ’buffalo hump’. After a...

ea0098b10 | Basic Science | NANETS2023

Notch1 and Notch3 signaling interplay regulates pancreatic neuroendocrine cell proliferation

Guenter Rachael , Chen Weisheng , Golivi Yuvasri , Robledo Mario , Jaskula-Sztul Renata , Chen Herbert , Rose Bart

Background: The 5-year survival rate for patients with advanced pancreatic neuroendocrine tumors (pNETs) is less than 30%. Notch signaling is a transmembrane receptor pathway with four distinct isoforms, activation of which is linked to cellular differentiation, cell fate, and viability. Both Notch1 and Notch3 signaling have been shown to be dysregulated in pNETs. Notch3 activation has been shown to repress Notch1 activity in other cancers. We hypothesize that activation of No...

ea0099ep10 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

The diagnosis and treatment of lipodystrophy: the experience of a portuguese tertiary centre

Barbosa Renata , Assuncao Guilherme , Saraiva Miguel , Ferreira Lia , Carvalho Rui , Fonseca Liliana

Introduction: This study presents four clinical cases of lipodystrophies, which are a group of rare and heterogeneous diseases characterized by the decrease or lack of adipose tissue (AT) accompanied by metabolic complications.Clinical cases: 1) 59-year-old woman with partial familial lipodystrophy, type 7 (OMIM #606721): Diagnosis of suspected type 1 diabetes (DM) at 28 (treated with insulin with poor control), class 1 obesity and hypertriglyceridemia. ...

ea0099ep548 | Reproductive and Developmental Endocrinology | ECE2024

Beyond the surface: endocrinological implications of thoracic endometriosis syndrome

Czapla-Iskrzycka Aleksandra , Pietrzak Katarzyna , Świątkowska-Stodulska Renata , Marjański Tomasz

Introduction: Thoracic Endometriosis Syndrome (TES) is characterized by clinical symptoms associated with menstruation (eg, catamenial pneumothorax (CP), chest pain, and others) not obligatorily requiring histological confirmation. The treatment is burdened with frequent recurrences. This study aimed to characterize the treatment of women with TES and assess the concomitant diseases.Methods: A developed online survey was published in patients’ suppo...

ea0081p342 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

IGF1-zSDS in patients suffering from obesity with or without metabolic syndrome: a cross-sectional study in 2032 subject

Masi Davide , Risi Renata , Tozzi Rossella , Gangitano Elena , Curreli Mariaignazia , Watanabe Mikiko , Mariani Stefania , Gnessi Lucio , Lubrano Carla

Background: Metabolic syndrome (MS) is associated with increased mortality, and the key factors predictive of its development among patients with obesity are still unclear. We recently demonstrated with a machine learning approach that Insulin-like Growth Factor 1 (IGF-1) is a novel marker of metabolic health and that in individuals with obesity, lower IGF-1 levels are associated with increased metabolic deterioration. However, the interpretation of IGF-1 serum measurement is ...

ea0090rc7.4 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

Effects of prolactin excess and treatment with cabergoline on bone mineral density and fracture risk in men

Del Vecchio Guendalina , Sorice Federica , Scairati Roberta , Pirchio Rosa , Meglio Sara Di , Pivonello Rosario , Colao Annamaria , Aurie mma Renata Simona

Purpose: The present study aims to investigate the effects of hyperprolactinemia (HPRL) and its pharmacological control with Cabergoline (CAB) on the risk of fractures in male patients affected by prolactinoma.Methods: Observational single-center study was conducted on 39 male patients (median age 49±12,4 y) with prolactinoma, including 37 with macroprolactinoma and 2 with empty sellae. In patients PRL levels at diagnosis (PRL 0’), PRL at evalu...

ea0090p34 | Calcium and Bone | ECE2023

Two cases of parathyromatosis in patients with recurrent primary hyperparathyroidism

Matejkova Behanova Magdalena , Libansky Petr , Vaculova Marketa , Chmelova Renata , Personova Kateřina , Vcelak Josef , Vlcek Petr

Introduction: Parathyromatosis is a rare cause of recurrent hyperparathyroidism defined as small nodules of hyperfunctioning parathyroid tissue in the soft tissues of the neck or mediastinum. The most common cause is probably the implantation of parathyroid cells into surrounding tissue during surgery and the risk of parathyromatosis increases with repeated parathyroid surgery. There is an overlap in the histologic features in parathyromatosis, atypical adenoma, and parathyroi...

ea0090p413 | Pituitary and Neuroendocrinology | ECE2023

Sleep Disorders And Osas Risk in Patients with Prolactinoma: A Single Center Experience

Del Vecchio Guendalina , Sorice Federica , Scairati Roberta , Pirchio Rosa , Di Meglio Sara , Pivonello Rosario , Colao Annamaria , Simona Auriemma Renata

Purpose: Dopaminergic system is implicated in the development of sleep disorders, and dopaminergic agents are used in clinical practice to treat daytime sleepiness and sleep disorders. The present study aimed at investigating the effects of hyperprolactinemia and its control with dopamine-agonists (DA) on sleep quality, excessive daytime sleepiness (ESS) and risk of obstructive sleep apnea syndrome (OSAS) in prolactinomas.Methods: A single-centre study w...